Dr. Anne Newman

The ICFSR 2024 Lifetime Achievement Award is awarded to Dr. Anne Newman for her pivotal contributions to the field of sarcopenia and frailty research related to our understanding of the life-course trajectories of muscle performance, physical functioning, and the onset of physical disability. Her work has provided a critical framework for our understanding of how the patho-physiological processes of aging influence the independence of older adults.

Keynotes speakers 2024


David Cella

David Cella, PhD Professor and Founding Chair, Department of Medical Social Sciences, Chicago (USA)

“Patient-reported and performance outcomes relevant to sarcopenia“

David Cella, PhD is Professor and the Ralph Seal Paffenbarger Chair Emeritus in the Department of Medical Social Sciences at the Northwestern University Feinberg School of Medicine. He is an elected member of the National Academy of Medicine and the Academy of Behavioral Medicine Research, and a fellow of the American Society of Clinical Oncology.
Dr. Cella developed and is continually refining the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System for outcome evaluation in patients with chronic medical conditions. He also led the development of the NIH Roadmap Initiative to build a Patient Reported Outcome Measurement Information System (PROMIS), the Neurology Quality of Life (Neuro-QoL) Measurement System, and the Emotional Health domain of the NIH Toolbox. He studies questions regarding quality-of-life measurement in clinical trials, cross-cultural equivalence of quality of life measurement, efficacy of psychosocial interventions in chronic illness, and medical outcomes research. He has published more than 1,000 peer-reviewed articles, most of which focus on the unique contribution that the patient perspective has upon the evaluation of health and health care. Dr. Cella has studied quality of life as a scientific enterprise, bringing the voice of the patient into consideration of value and opportunities for improvement on the healthcare system. For this, he was awarded the NAM Gustav O. Lienhard Award for Advancement of Health Care in 2016.

Anne Newman

Anne Newman, MD, MPH University of Pittsburgh, PA, USA

“Health ABC to SOMMA: Leaning into aging biology to understand frailty and sarcopenia“

Anne B. Newman, MD, MPH is Distinguished Professor of Epidemiology and Professor of Medicine and Clinical and Translational Science in the School of Medicine. She is the Clinical Director of the Aging Institute of the University of Pittsburgh and UPMC and UPMC Chair of Geroscience. She has defined key metrics of physical functioning, frailty, and sarcopenia in epidemiology cohort studies, and has conducted clinical trials designed to prevent disability and extend health span.
She currently serves as a member of the National Institute on Aging Clinical Trials Advisory Panel (CTAP), and has completed service as a member of the Board of Scientific Counselors and the National Advisory Council on Aging.
She is a member of the American Federation for Aging Research(AFAR) National Scientific Advisory Council. Dr. Newman is also an Associate Editor of the Journal of Gerontology, Medical Sciences, after serving as the Editor-in Chief from 2016-2020.

Yves Rolland

Yves Rolland, MD, PhD Gerontopôle of Toulouse, University Toulouse Paul Sabatier, Toulouse (France)

“Current and investigational medications for the treatment of sarcopenia“

Yves Rolland, MD, PhD is a Professor of Internal Medicine and Geriatrics at the Gerontopôle of Toulouse (France) and has a postgraduate diploma in sports medicine. He is member of the CERPO Team, UMR1295 (INSERM) at the University Toulouse III Paul Sabatier (MAINTAIN - MAintain Functions and INTrinsec capacities with Aging: Preventive and Personalized INterventional Research). He is the Editor in chief of the Journal of Nursing Home Research (JNHR). He is the author of more than 400 articles indexed Pubmed including around 80 articles related to Nursing Home care.

Gustavo Duque

Gustavo Duque, MD, PhD McGill University Health Centre, Montréal, Québec (Canada)

“Osteosarcopenia and the crossroad between muscle, bone and fat“

Professor Gustavo Duque, MD, Ph.D., FRACP, is a geriatrician and biomedical scientist with a research interest in the mechanisms, potential therapies, and biomarkers for age-related bone loss, osteoporosis, sarcopenia, osteosarcopenia, and frailty in older persons. Prof. Duque is Full Professor, Dr. Joseph Kaufmann Chair in Geriatric Medicine, Director - RUISSS McGill Centre of Excellence for Sustainable Health of Seniors/ Simone & Edouard Shouela (CEDurable), and Principal Investigator at the Bone, Muscle & Geroscience Group of the Research Institute of the McGill University Health Centre (MUHC). He is also the Editor-in-Chief of the Journal of Gerontology: Biological Sciences, one of the official journals of the Gerontological Society of America. His clinical trials unit conducts several trials testing the effect of pharmacological and non-pharmacological treatments for frailty and age-related musculoskeletal diseases. He is the author of more than 290 peer-reviewed articles and multiple book chapters and has edited five books in the aging and musculoskeletal fields (two on osteosarcopenia).

Luigi Ferrucci

Luigi Ferrucci, MD, PhD National Institute on Aging/NIH, Baltimore, Maryland (USA)

“Translational Research on Mitochondria and Aging Frailty & Sarcopenia“

Dr. Luigi Ferrucci is a geriatrician and an epidemiologist who conducts research on the causal pathways leading to progressive physical and cognitive decline in older persons. He has made major contributions in the design of many epidemiological studies conducted in the U.S. and in Europe. Dr. Ferrucci received a Medical Degree and Board Certification in 1980, Board Certification in Geriatrics in 1982 and Ph.D. in Biology and Pathophysiology of Aging in 1998 at the University of Florence, Italy. Between 1985 and 2002 he was Chief of Geriatric Rehabilitation at the Department of Geriatric Medicine and Director of the Laboratory of Clinical Epidemiology at the Italian National Institute of Aging. In September 2002, he became the Chief of the Longitudinal Studies Section at NIA. From 2002 to 2014 he was the Director of the Baltimore Longitudinal Study on Aging. Dr. Ferrucci is currently the Scientific Director of NIA, since May 2011.

Rafael de Cabo

Rafael de Cabo, PhD National Institute on Aging, Baltimore (USA)

“Study of Longitudinal Aging in Mice (SLAM)“

After receiving his B.Sc. and M.Sc. from the University of Córdoba, Spain, Dr. de Cabo earned his Ph.D. in 2000 from the Department of Foods and Nutrition at Purdue University before joining the Laboratory of Neurosciences at the National Institute on Aging in Baltimore, Maryland, as a postdoctoral fellow. In 2004, he was appointed as a tenure track investigator in the Laboratory of Experimental Gerontology, and is now a senior investigator and Chief of the Translational Gerontology Branch at NIA. He is the author or coauthor of 320 publications.
His research has focused on improving our understanding of the molecular mechanisms underlying the effects of caloric restriction on aging, and pharmacological interventions for healthy aging. Dr. de Cabo’s honors and awards include Purdue University Diamond Award, Department of Foods and Nutrition (2016), AFAR’s Vince Cristofalo Rising Star Award (2014), Fellow of the Gerontological Society of America (2010), Nathan Shock New Investigator Award of the Gerontological Society of America (2006), Paul E. Glenn Award for Meritorious Research from The American Aging Association.
Dr de Cabo is Deputy Editor in Chief of the Journal of Gerontology Biological Sciences, serves on the editorial boards of Aging Cell, BBA-Molecular Mechanisms of Disease, Aging Research Reviews, Longevity & Healthspan, Impact Aging, and AGE, and is one of the founding editors of Microbial Cell.

Francesco Landi

Francesco Landi, MD, PhD, Catholic University of Rome (Italy)

“The New Challenges of Healthy Longevity: From the Sprint-t Study to the Longevity Run Project“

Francesco Landi is Associate Professor of Internal Medicine at the Catholic University of Rome, School of Medicine. He is the chief of the Geriatric Internal Medicine Unit of the Geriatrics Department of the A. Gemelli University Hospital. He has been a visiting Assistant Professor at Brown University School of Medicine, Department of Community Health.
Contributions to advance scientific knowledge and medical practice include active involvement in research and the application to patient care. Main research interests are in geriatric assessment, nutritional problems, sarcopenia, models of health services for elderly care, and geriatric pharmaco-epidemiology. Prof. Landi serves as a President of the Scientific Committee of the Italian Geriatric Society, on the Editorial Board of several international geriatric journals, and as a peer reviewer for numerous international medical journals. He has acted as the Principal Investigator in many multicenter national and international trials. In addition, he is a member of national and international expert groups that work on guidelines in the field of nutrition, sarcopenia and functionality in older adults.
Prof. Landi has over 300 peer-reviewed original papers in international medical journals, many of which are in the area of frailty and functional status of older people. He is particularly interested in the role of nutrition as part of the integrated care of older adults, and participated in the development of the European consensus on sarcopenia definition and diagnosis.

ICFSR24 Program highlights

  • • Patient-reported outcomes in frailty and sarcopenia
  • • Current and investigational medications for the treatment of sarcopenia
  • • Osteosarcopenia and the crossroad between muscle, bone and fat
  • • Translational Research on Mitochondria and Aging Frailty & Sarcopenia
  • • Icope / integrated Care for older persons and maintaining intrinsic capacities for healthy longevity
  • • Diversity and Equity in Frailty and Sarcopenia
  • • Aging and homelessness: what challenges lie ahead?
  • • Clinical and drug trials in frailty and sarcopenia

Abstracts ICFSR 2023


Abstracts ICFSR 2022